C12Y 301/03005
5'-nucleotidase
Official title: 5'-Nucleotidase (3.1.3.5)
C12Y301/03005 (5'-nucleotidase) appears on 18 US grants and 53 published applications in this corpus.
Search patents in C12Y- Granted patents
- 18
- Published applications
- 53
- Assignees
- 39
- Inventors
- 148
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 3 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 2 |
| 2013 | 1 | 1 |
| 2014 | 2 | 1 |
| 2015 | 0 | 3 |
| 2016 | 0 | 4 |
| 2017 | 1 | 2 |
| 2018 | 3 | 2 |
| 2019 | 0 | 1 |
| 2020 | 1 | 3 |
| 2021 | 0 | 3 |
| 2022 | 1 | 5 |
| 2023 | 4 | 10 |
| 2024 | 1 | 1 |
| 2025 | 0 | 8 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nanometric pharmaceutical composition in the form of liposomes or nanoemulsion containing specific sequences of interference RNA18 Aug 2026US 12,708,671 B2
- Universal donor cells24 Feb 2026US 12,559,726 B2Crispr Therapeutics AG
- Nicotinamide riboside production in filamentous fungi14 May 2024US 11,981,889 B2Dyadic International (USA), Inc.
- Recombinant microorganism for producing citicoline and method for producing citicoline29 Aug 2023US 11,739,357 B2Suzhou Biosynthetica Co., Ltd
- Anti-CD73 antibodies and compositions25 Apr 2023US 11,634,500 B2Les Laboratoires Servier
- Cd39 and cd73 for the therapy of hemorrhagic shock12 Feb 2026US 2026/0041741 A1The Trustees of Columbia University in the City of New York
- Nanobody and nanobody-drug conjugate targeting cd73, method for preparing same, and use thereof18 Dec 2025US 2025/0382376 A1Fudan University
- Biomarkers and methods for treating nsclc20 Nov 2025US 2025/0352645 A1I-Mab Biopharma Co., Ltd.
- Combination Of Proteotypic Peptides For The Detection Of Proteins In The Pd-L1 Axis28 Aug 2025US 2025/0271446 A1The Royal Institution for the Advancement of Learming/McGill University
- Fish, method for producing fish, and method for producing fish exhibiting accelerated maturation22 May 2025US 2025/0160306 A1Kinki University
Most cited
By later US patents
- Asparaginases and method of preparing a heat-treated product12US 7,396,670 B2Novozymes A/S · 2008
- Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases10US 8,784,805 B2Alloksys Life Sciences B.V. · 2014
- Universal donor cells6US 11,566,230 B2Crispr Therapeutics AG · 2023
- Universal donor cells6US 11,578,309 B2Crispr Therapeutics AG · 2023
- Immunogenic fusion proteins for the treatment of cancer6US 9,808,516 B2Aduro Biotech, Inc. · 2017